Intellia Therapeutics (NTLA) Prepaid Assets (2015 - 2026)
Intellia Therapeutics' (NTLA) quarterly Prepaid Assets came in at $81.3 million in Q1 2026, up 118.98% year-on-year from $37.1 million in Q1 2025, and up 18.98% on a QoQ basis from $68.4 million in Q4 2025.
Intellia Therapeutics (NTLA) Prepaid Assets (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has 12 years of Prepaid Assets data on file, last reported at $81.3 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 118.98% year-over-year to $81.3 million in Q1 2026; TTM through Mar 2026 was $81.3 million, a 118.98% increase from a year earlier, with the FY2025 full-year figure at $68.4 million, up 129.15% from the prior year.
- Prepaid Assets for Q1 2026 stood at $81.3 million, up from $68.4 million in the prior quarter.
- Over the last five years, Prepaid Assets for NTLA reached as high as $81.3 million in Q1 2026 and fell as low as $18.3 million in Q2 2022.
- Historically, Prepaid Assets has averaged $39.6 million across 5 years, with a median of $32.2 million in 2023.
- Across the five-year window, Prepaid Assets soared 143.3% in 2023 and sank 53.65% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $20.4 million in 2022, then jumped by 143.3% to $49.7 million in 2023, then plunged by 39.92% to $29.8 million in 2024, then surged by 129.15% to $68.4 million in 2025, then climbed by 18.98% to $81.3 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $81.3 million in Q1 2026, $68.4 million in Q4 2025, and $59.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.33 Mn |
| Dec 31, 2025 | 68.36 Mn |
| Sep 30, 2025 | 59.85 Mn |
| Jun 30, 2025 | 24.94 Mn |
| Mar 31, 2025 | 37.14 Mn |
| Dec 31, 2024 | 29.83 Mn |
| Sep 30, 2024 | 43.93 Mn |
| Jun 30, 2024 | 53.81 Mn |
| Mar 31, 2024 | 56.32 Mn |
| Dec 31, 2023 | 49.65 Mn |
| Sep 30, 2023 | 32.21 Mn |
| Jun 30, 2023 | 26.49 Mn |
| Mar 31, 2023 | 25.22 Mn |
| Dec 31, 2022 | 20.41 Mn |
| Sep 30, 2022 | 26.73 Mn |
| Jun 30, 2022 | 18.30 Mn |
| Mar 31, 2022 | 18.32 Mn |
| Dec 31, 2021 | 18.58 Mn |
| Sep 30, 2021 | 14.02 Mn |
| Jun 30, 2021 | 18.39 Mn |